Croscarmellose Sodium (Cel-Ca-Dissol) represents a high-performance superdisintegrant excipient specifically engineered for pharmaceutical tablet formulations. As the sodium salt o...

Croscarmellose Sodium (Cel-Ca-Dissol) represents a high-performance superdisintegrant excipient specifically engineered for pharmaceutical tablet formulations. As the sodium salt of cross-linked carboxymethylcellulose, it excels in rapidly disintegrating tablets through its unique water absorption and swelling mechanism. This action creates mechanical pressure that efficiently breaks down dosage forms, ensuring active pharmaceutical ingredients release quickly and completely. The significantly enhanced dissolution rates directly improve bioavailability, making medications more effective. Its insoluble, sponge-like nature provides consistent performance without dissolving during the process. With excellent flow properties and broad compatibility, it integrates seamlessly into manufacturing operations while maintaining compliance with global pharmacopeial standards including USP, NF, and EP.

This superior excipient finds extensive application throughout the pharmaceutical industry, particularly in manufacturing immediate-release tablets for pain relievers, antibiotics, antivirals, and antihistamines. It plays a crucial role in formulating orally disintegrating tablets for patients with swallowing difficulties, including pediatric and geriatric populations. The nutraceutical sector relies on it for vitamin and mineral supplements where rapid disintegration ensures improved nutrient absorption. Additionally, it serves effervescent tablets and chewable formulations where quick breakdown is essential for user convenience and product efficacy. Its proven reliability makes it the preferred choice for contract manufacturing organizations and large pharmaceutical companies seeking compliance and manufacturing efficiency.

Manufacturers benefit from croscarmellose sodium through its exceptional cost-effectiveness, as low concentrations between 0.5-5% deliver maximum disintegration power, reducing material costs without compromising performance. The excipient's extended shelf life and stability under varying storage conditions minimize product waste while ensuring long-term integrity. Its remarkable consistency guarantees batch-to-batch uniformity, reducing manufacturing delays and enhancing overall productivity. The material's compatibility with diverse formulations allows manufacturers to optimize properties for specific active ingredients, providing formulation flexibility and competitive advantages. By significantly improving dissolution rates, it helps companies meet stringent regulatory requirements for bioavailability, accelerating time-to-market for new medications while strengthening market positioning.

Key Features:
- Rapid water absorption and swelling mechanism for fastest tablet disintegration
- High effectiveness at low usage levels between 0.5% to 5% of tablet weight
- Insoluble and sponge-like structure ensuring consistent performance without dissolution
- Excellent flow properties for easy handling and blending during manufacturing
- Compliance with global pharmacopeial standards including USP, NF, and EP

Benefits:
- Enhanced dissolution rates leading to improved bioavailability of active ingredients
- Cost efficiency through low usage concentrations reducing material expenses
- Extended shelf life and stability under various storage conditions minimizing waste
- Consistent batch-to-batch uniformity reducing manufacturing delays and enhancing productivity
- Regulatory compliance support helping accelerate time-to-market for new formulations